What's new? Log in Free sign up

GreenLight Biosciences (GRNA) News and press releases

Company Profile

News

From Benzinga Pro

Benzinga's Top Ratings Upgrades, Downgrades For May 31, 2023

Upgrades, Downgrades, Initiation, Intraday Update, Analyst Ratings

Canaccord Genuity Downgrades GreenLight Biosciences to Hold, Lowers Price Target to $0.3

News, Downgrades, Price Target, Analyst Ratings

Canaccord Genuity analyst Bobby Burleson downgrades GreenLight Biosciences (NASDAQ:GRNA) from Buy to Hold and lowers the price target from $4 to $0.3.

12 Health Care Stocks Moving In Tuesday's Intraday Session

Why Nvidia Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Long Ideas, News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas

Gainers QualTek Services Inc. (NASDAQ: QTEK) shares jumped 127.2% to $0.1740 after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter 11 bankruptcy.

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Stocks That Hit 52-Week Lows On Monday

On Monday, 85 stocks hit new 52-week lows.

Stocks That Hit 52-Week Lows On Thursday

Thursday's session saw 189 companies set new 52-week lows.

Recap: GreenLight Biosciences Q1 Earnings

GreenLight Biosciences Q1 EPS $(0.19) Beats $(0.23) Estimate, Sales $3.82M Beat $1.00M Estimate; Cash And Equivalents Of $32.4M Will Be Sufficient To Fund Planned Operating Expenses And Capital Expenditures, Into Q2 Of 2023

GreenLight Biosciences (NASDAQ:GRNA) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.23) by 17.39 percent. This is a 44.12 percent increase over losses of $(0.34) per share

Stocks That Hit 52-Week Lows On Thursday

On Thursday, 498 companies reached new 52-week lows.

Stocks That Hit 52-Week Lows On Thursday

On Thursday, 185 companies achieved new lows for the year.

Stocks That Hit 52-Week Lows On Monday

On Monday, 147 stocks made new 52-week lows.

12 Health Care Stocks Moving In Monday's Pre-Market Session

Fall Line Endurance Fund, In Amended 13D Filing, Submitted Preliminary Non-binding Proposal For Greenlight Biosciences For Cash Consideration Of US$0.60/Share

https://www.sec.gov/Archives/edgar/data/1675025/000119312523084409/d453299dsc13da.htm

GreenLight Biosciences Q4 EPS $(0.26) Misses $(0.25) Estimate, Sales $3.02M Beat $1.60M Estimate

GreenLight Biosciences (NASDAQ:GRNA) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate of $(0.25) by 4 percent. The company reported quarterly sales of $3.02 million which beat

Stocks That Hit 52-Week Lows On Friday

On Friday, 497 companies set new 52-week lows.

Press releases

From Benzinga Pro

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FRG, HMPT, GRNA

NEW YORK , June 6, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary

GRNA ALERT: Levi & Korsinsky, LLP Announces an Investigation of Greenlight Biosciences

NEW YORK, June 5, 2023 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP:

Lifshitz Law PLLC Announces Investigations of GRNA, AAIC, EMBK, and REUN

News, Legal, Press Releases

NEW YORK, June 03, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences Holdings, PBC (NASDAQ:GRNA) Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EMBK, AAIC, GRNA

News, Legal, Press Releases

NEW YORK, June 01, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary

GREENLIGHT BIOSCIENCES INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of GreenLight Biosciences Holdings, PBC - GRNA

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of GreenLight Biosciences Holdings, PBC (NASDAQGM:GRNA) to a

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating GreenLight Biosciences Holdings Buyout

Wilmington, Delaware--(Newsfile Corp. - May 31, 2023) - Rigrodsky Law, P.A. is investigating GreenLight Biosciences Holdings ("GreenLight") (NASDAQ:GRNA) regarding possible breaches of fiduciary duties and other

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GRNA, AAIC, CWBR, EMBK

NEW YORK, May 30, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties

Shareholder Alert: Ademi LLP investigates whether GreenLight Biosciences Holdings, PBC has obtained a Fair Price in its transaction with Fall Line

MILWAUKEE, May 30, 2023 /PRNewswire/ -- Ademi LLP is investigating GreenLight (NASDAQ:GRNA) for possible breaches of fiduciary duty and other violations of law in its transaction with Fall Line. Click here to learn how

GRNA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of GreenLight Biosciences Holdings, PBC Is Fair to Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of GreenLight Biosciences Holdings, PBC (NASDAQ:GRNA) to a group of buyers led by Fall Line Capital, LLC for $0.30 per share is fair to

GreenLight Biosciences Enters into Definitive Merger Agreement with Consortium Led by Fall Line Endurance Fund for Go-Private Transaction

M&A, News, Press Releases

LEXINGTON, Mass., May 30, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences Holdings, PBC (NASDAQ:GRNA) ("GreenLight" or the "Company") today announced that the Company has entered into a definitive agreement (the

GreenLight Biosciences Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress

Earnings, Press Releases

BOSTON, May 11, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences, PBC (NASDAQ:GRNA), a biotechnology company dedicated to making RNA products affordable and accessible for human health and agriculture, today reported

GreenLight Biosciences Releases Inaugural Sustainability Report

BOSTON, April 12, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences (NASDAQ:GRNA), a public benefit corporation striving to deliver on the full potential of RNA to address some of the world's toughest problems in human

GreenLight Biosciences Holdings Confirms Receipt of Indication of Interest from Fall Line

M&A, News, Press Releases

BOSTON, March 30, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences (NASDAQ:GRNA) ("GreenLight" or the "Company"), a public benefit corporation striving to deliver on the full potential of RNA to address some of the

GreenLight Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results

Earnings, Press Releases

Two agriculture solutions now under regulatory review, pending EPA approval: Calantha™, a solution to protect potatoes, and a separate solution to protect honeybees from Varroa miteUpdated clinical strategy to

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.